Trially
Kansas City
About Trially
Trially is the first AI-native clinical trial enrollment platform that matches, engages and enrolls patients at breakthrough speed and ~95% accuracy. Loved by customers, Trially LLM agents fill trials faster’with 2-6x increase in enrollment rate, 73% fewer screen fails, and 91% less prescreening time. Trially’s site-based software rapidly prescreens patients from any clinical data source, fully compliant with HIPAA, SOC 2, FDA 21 CFR Part 11, and ISO 27001. Designed to meet the needs of Physicians, Sites, Sponsors and CROs, Trially AI empowers you to achieve outstanding results in clinical research.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.7M
- Funding stage: Seed
- Last round: Seed (Sep 2025)
- Website: trially.ai
Industries & Categories
Artificial Intelligence (AI), Clinical Trials, Data Integration, Health Care, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/trially-38033 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.